Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Scaradavou, Andromachi  [Clear All Filters]
2020
Politikos I, Davis E, Nhaissi M, Wagner JE, Brunstein CG, Cohen S, Shpall EJ, Milano F, Scaradavou A, Barker JN. Guidelines for Cord Blood Unit Selection. Biol Blood Marrow Transplant. 2020.
2022
Scaradavou A, Boelens JJan. Lower probability of relapse after myeloablative cord blood transplantation for patients with refractory AML. Br J Haematol. 2022.
2023
Tamari R, Scordo M, Kunvarjee B, Proli A, Lin A, Flynn JR, Cho C, Devlin SM, Klein E, Boulad F, et al. Association between busulfan exposure and survival in patients undergoing a CD34+ selected stem cell transplantation. Blood Adv. 2023.
Scaradavou A. Cord Blood Stem Cells Do Not "Age": Under Proper Banking Conditions. Stem Cells Transl Med. 2023.
Kunvarjee B, Bidgoli A, Madan RPellett, Vidal E, McAvoy D, Hosszu KK, Scaradavou A, Spitzer BG, Curran KJ, Cancio M, et al. Emapalumab as bridge to hematopoietic cell transplant for STAT1 gain-of-function mutations. J Allergy Clin Immunol. 2023.
Lucas AGTroullio, Boelens JJan, Prockop SE, Curran KJ, Bresters D, Kollen W, Versluys B, Bierings MB, Archer A, Davis E, et al. Excellent leukemia control after second hematopoietic cell transplants with unrelated cord blood grafts for post-transplant relapse in pediatric patients. Front Oncol. 2023;13:1221782.
Satty AM, Klein E, Mauguen A, Kunvarjee B, Boelens JJan, Cancio M, Curran KJ, Kernan NA, Prockop SE, Scaradavou A, et al. T-cell depleted allogeneic hematopoietic stem cell transplant for the treatment of Fanconi anemia and MDS/AML. Bone Marrow Transplant. 2023.
2024
Lakkaraja M, Mauguen A, Boulad F, Cancio MI, Curran KJ, Harris AC, Kernan NA, Klein E, Kung AL, Oved J, et al. Impact of rabbit anti-thymocyte globulin (ATG) exposure on outcomes after ex vivo T-cell-depleted hematopoietic cell transplantation in pediatric and young adult patients. Cytotherapy. 2024.
Kernan NA, Klein E, Mauguen A, Torok-Castanza J, Prockop SE, Scaradavou A, Curran K, Spitzer B, Cancio M, Ruggiero J, et al. Persistent or new cytopenias predict relapse better than routine bone marrow aspirate evaluations after hematopoietic cell transplantation for acute leukemia or myelodysplastic syndrome in children and young adult patients. Transplant Cell Ther. 2024.
Major-Monfried H, Hosszu K, McAvoy DP, Vallone A, Shukla N, Gillio A, Spitzer B, Kung AL, Cancio M, Curran K, et al. Two novel assays demonstrate persistent daratumumab exposure in a pediatric patient with delayed engraftment following allogeneic hematopoietic stem cell transplantation. Cytotherapy. 2024.